Market Research Report
Regenerative Medicine Market
|Published by||Progressive Markets Research||Product code||649309|
|Published||Content info||165 Pages
Delivery time: 1-2 business days
|Regenerative Medicine Market|
|Published: April 1, 2018||Content info: 165 Pages||
The global regenerative medicine market was valued at $6677.7 million in 2017 and is expected to reach $64919.7 million by 2025, registering a CAGR of 33.05% during 2018-2025. Regenerative medicine is a new and fast developing field of medicine. It holds the promise of regenerating or restoring the organs and tissues in the body which are lost due to age, disease, damage, or birth abnormalities. The technique involves the use of stem cells to treat diseases or injuries using cell therapies or transplantation methods. Regenerative medicine also allows scientists to grow tissues and organs in the laboratory and implant them securely in the affected area in the body. This procedure is performed when the body cannot heal itself. This branch of medicine finds application in numerous fields including dermatology, cardiovascular diseases, osteoporosis, oncology, neurology, severe burns, spinal cord injury, congenital abnormalities, and others.
The report the drivers and restraints impacting the growth of the regenerative market. Factors such as the rapid advancement of technology for the restorations of organs and tissues, the growing prevalence of chronic diseases worldwide, the increase in the government and private funding for the development of regenerative diseases, and the growth in geriatric population are causing the industry to grow fast. Whereas, the high cost of regenerative medicines and stringent government regulations impede the growth of the regenerative medicine market.
The report offers details about the prominent players providing solution in the regenerative medicine market. The details include information about their products and specifications, the marketing strategies adopted by them to sustain in the field, their market size and share, and more. The key players mentioned in the research study include Zimmer Biomet Holdings, Inc., Medtronic plc, Stryker Corporation, Ocata Therapeutics, Inc., Baxter International, Inc., DePuy Synthes, Organogenesis, Inc., Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., and CryoLife, Inc.
5.2.1 Historical market size by region, 2014-2016
5.2.2 Market forecast by region, 2017-2025
5.2.3 Deoxyribonucleic acid transfection vectors
5.2.4 Genetically manipulated cells
188.8.131.52 Historical market size by region, 2014-2016
184.108.40.206 Market forecast by region, 2017-2025